MedTrace Logo

PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers

NCT01826110 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-03-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the radiotracer \[11C\] PIB in participants with probably Alzheimer's Disease (AD) and healthy age-matched controls.

Conditions

Interventions

DRUG

[11C]PIB

Approximately 15 mCI \[11C\]PIB IV x1

Sponsors & Collaborators

Principal Investigators

  • Dean F Wong, MD, PhD · Johns Hopkins University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01826110 on ClinicalTrials.gov